This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Kim, K. et al. Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis. Brain https://doi.org/10.1093/brain/awaa421 (2020)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wood, H. Neddylation — a new therapeutic target for multiple sclerosis?. Nat Rev Neurol 17, 64 (2021). https://doi.org/10.1038/s41582-021-00460-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-021-00460-5